The compounds are oral small molecules based on three distinct mechanistic platforms: calcitonin gene-related peptide (CGRP) receptor antagonists, glutamate modulators, and myeloperoxidase inhibitors.

In addition, Biohaven has several other programs in development, including a CGRP-receptor antagonist for episodic and chronic migraine, and glutamate modulators for multiple neurologic and ...

The company, launched with help from ex-Novartis executives, is targeting glutamate signaling in the brain to help treat alcohol- and cocaine-use disorders, among other indications.

Arthur Burns is a 1 st year MS student in the Neuroscience program working on his master’s project in our lab. He is characterizing modulators of glutamate transporters in conditioned place preference ...

The Italian biopharma said it had decided to press ahead with the new study after assessing results from 100 patients with TRS in open-label studies who received the glutamate modulator drug as an ...

Newron Pharmaceuticals SpA ( ($CH:NWRN) ) has issued an announcement. Newron Pharmaceuticals reported a net profit of EUR 15.8 million for 2024, a ...

Headquartered in Bresso, near Milan, Italy, Newron is advancing its lead compound, evenamide, a first-in-class glutamate modulator, which has the potential to be the first add-on therapy for ...